Blog | Veristat Insightful Perspectives

What Matters Most in the Clinical Study Feasibility Process

From  Site Selection to Protocol Development: A Thorough Approach to the Feasibility Process

Read More

Regulatory Guidance Monthly Review - August 2019

August 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided in August 2019.


Read More